Stock & Company Details
Clene Inc $CLNN
Price:
N/A
N/A
14M
$50M
52 Week High:
N/A
10 Day Average Volume:
N/A
-1.00
50 Day Moving Average:
N/A
52 Week Low:
N/A
30 Day Average Volume:
N/A
N/A
N/A
N/A
30 Day Change:
N/A
3 Month Change:
N/A
Health Technology
CLNN technical indicators
Latest Clene Inc (CLNN) indicator readings as of 2026-11-19.
CLNN's 14-day RSI is 42.7, in neutral territory. ADX reads 14.3, indicating a range-bound market rather than a trend. MACD (12, 26, 9) is -0.08, below the zero line.
Overview
Clene is a clinical-stage biopharmaceutical company focused on the development of unique therapeutics for neurodegenerative diseases. Clene has innovated a novel nanotechnology drug platform for the development of a new class of orally administered neurotherapeutic drugs. Clene has also advanced into the clinic an aqueous solution of ionic zinc and silver for anti-viral and anti-microbial uses. Founded in 2013, the company is based in Salt Lake City, Utah with R&D and manufacturing operations located in North East, Maryland.
Finance Bot
Ask your questions
Start by typing a question below.